Niuminco EBITDA margin
Qual é o EBITDA margin de Niuminco?
O EBITDA margin de Niuminco Group Limited é -383.18%
Qual é a definição de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de empresas na Setor Materials em ASX em comparação com Niuminco
O que Niuminco faz?
Niuminco Group Limited, through its subsidiaries, engages in the exploration and evaluation of mineral properties. The company primarily explores for gold, silver, and copper deposits. It holds a 100% interest in the May River and Bolobip exploration licenses; and the Edie Creek mining leases located in Papua New Guinea. The company was incorporated in 2006 and is based in Belrose, Australia.
Empresas com ebitda margin semelhantes a Niuminco
- Wrap Technologies tem EBITDA margin de -387.37%
- Concurrent Computer tem EBITDA margin de -384.81%
- CCUR tem EBITDA margin de -384.81%
- Nagambie Resources tem EBITDA margin de -384.51%
- OSE Immunotherapeutics SA tem EBITDA margin de -383.51%
- Northern Minerals tem EBITDA margin de -383.45%
- Niuminco tem EBITDA margin de -383.18%
- INVO Bioscience tem EBITDA margin de -383.06%
- Alterra tem EBITDA margin de -382.96%
- Adamis Pharmaceuticals Corp tem EBITDA margin de -382.23%
- Voluntis S.A tem EBITDA margin de -379.54%
- Evgen Pharma plc tem EBITDA margin de -379.12%
- American Resources tem EBITDA margin de -378.54%